320 related articles for article (PubMed ID: 17270273)
21. Protein dynamics and imidazole binding in cytochrome P450 enzymes.
Verras A; Ortiz de Montellano PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778
[TBL] [Abstract][Full Text] [Related]
22. Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment.
Meyer RP; Gehlhaus M; Schwab R; Bürck C; Knoth R; Hagemeyer CE
J Neurochem; 2009 Apr; 109(2):670-81. PubMed ID: 19226368
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
24. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry.
Redlich G; Zanger UM; Riedmaier S; Bache N; Giessing AB; Eisenacher M; Stephan C; Meyer HE; Jensen ON; Marcus K
J Proteome Res; 2008 Nov; 7(11):4678-88. PubMed ID: 18828626
[TBL] [Abstract][Full Text] [Related]
25. The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes.
Testa B; Krämer SD
Chem Biodivers; 2007 Mar; 4(3):257-405. PubMed ID: 17372942
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction.
Girault I; Rougier N; Chesné C; Lidereau R; Beaune P; Bieche I; de Waziers I
Drug Metab Dispos; 2005 Dec; 33(12):1803-10. PubMed ID: 16135659
[TBL] [Abstract][Full Text] [Related]
27. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
Gillam EM
Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
29. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
Hollenberg PF; Kent UM; Bumpus NN
Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
[TBL] [Abstract][Full Text] [Related]
30. Novel extrahepatic cytochrome P450s.
Karlgren M; Miura S; Ingelman-Sundberg M
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
[TBL] [Abstract][Full Text] [Related]
31. The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders.
Haduch A; Daniel WA
Drug Metab Rev; 2018 Nov; 50(4):415-429. PubMed ID: 30501426
[TBL] [Abstract][Full Text] [Related]
32. [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance].
Guéguen Y; Mouzat K; Ferrari L; Tissandie E; Lobaccaro JM; Batt AM; Paquet F; Voisin P; Aigueperse J; Gourmelon P; Souidi M
Ann Biol Clin (Paris); 2006; 64(6):535-48. PubMed ID: 17162257
[TBL] [Abstract][Full Text] [Related]
33. Drug metabolizing enzyme expression in rat choroid plexus: effects of in vivo xenobiotics treatment.
Gradinaru D; Minn AL; Artur Y; Minn A; Heydel JM
Arch Toxicol; 2009 Jun; 83(6):581-6. PubMed ID: 19023562
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions.
Lee MD; Ayanoglu E; Gong L
Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450s in the development of target-based anticancer drugs.
Purnapatre K; Khattar SK; Saini KS
Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
[TBL] [Abstract][Full Text] [Related]
36. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
Kontijevskis A; Komorowski J; Wikberg JE
J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
[TBL] [Abstract][Full Text] [Related]
37. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms.
Zhu BT; Lee AJ
Steroids; 2005 Apr; 70(4):225-44. PubMed ID: 15784278
[TBL] [Abstract][Full Text] [Related]
38. Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs.
Toselli F; Dodd PR; Gillam EM
Drug Metab Rev; 2016 Aug; 48(3):379-404. PubMed ID: 27498925
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
Iyanagi T
Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
[TBL] [Abstract][Full Text] [Related]
40. Stochastic simulations of the cytochrome P450 catalytic cycle.
Wang Y; Li Y; Wang B
J Phys Chem B; 2007 Apr; 111(16):4251-60. PubMed ID: 17402779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
